Evidence map›Paper›PMID 31420396›Full record

ArticleBMJ open2019

Collaborative design of a decision aid for stroke survivors with multimorbidity: a qualitative study in the UK engaging key stakeholders.

Talya Porat, Iain J Marshall, Euan Sadler, Miguel A Vadillo, Christopher McKevitt, Charles D A Wolfe, Vasa Curcin

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. A scoping review of patient and public involvement in empirical stroke research.International journal of stroke : official journal of the International Stroke Society · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Talya PoratDyson School of Design Engineering, Imperial College London, London, UK.
Iain J MarshallSchool of Population Health and Environmental Sciences, King's College London, London, UK.ORCID 0000-0003-2594-2654
Euan SadlerSchool of Health Sciences, University of Southampton, UK.
Miguel A VadilloDepartamento de Psicología Básica, Universidad Autónoma de Madrid, Madrid, Spain.
Christopher McKevittSchool of Population Health and Environmental Sciences, King's College London, London, UK.
Charles D A WolfeSchool of Population Health and Environmental Sciences, King's College London, London, UK.ORCID 0000-0001-8264-0981
Vasa CurcinSchool of Population Health and Environmental Sciences, King's College London, London, UK.
King's College London · GBDyson (United Kingdom) · GBUniversidad Autónoma de Madrid · ESUniversity of Southampton · GB

Funding

Cancer Research UK 25310Medical Research Council MR/N015185/1
6 · The paper itself

Abstract

objectivesEffective secondary stroke prevention strategies are suboptimally used. Novel development of interventions to enable healthcare professionals and stroke survivors to manage risk factors for stroke recurrence are required. We sought to engage key stakeholders in the design and evaluation of an intervention informed by a learning health system approach, to improve risk factor management and secondary prevention for stroke survivors with multimorbidity.

designQualitative, including focus groups, semistructured interviews and usability evaluations. Data was audio recorded, transcribed and coded thematically.

participantsStroke survivors, carers, health and social care professionals, commissioners, policymakers and researchers.

settingStroke survivors were recruited from the South London Stroke Register; health and social care professionals through South London general practices and King's College London (KCL) networks; carers, commissioners, policymakers and researchers through KCL networks.

results53 stakeholders in total participated in focus groups, interviews and usability evaluations. Thirty-seven participated in focus groups and interviews, including stroke survivors and carers (n=11), health and social care professionals (n=16), commissioners and policymakers (n=6) and researchers (n=4). Sixteen participated in usability evaluations, including stroke survivors (n=8) and general practitioners (GPs; n=8). Eight themes informed the collaborative design of DOTT (Deciding On Treatments Together), a decision aid integrated with the electronic health record system, to be used in primary care during clinical consultations between the healthcare professional and stroke survivor. DOTT aims to facilitate shared decision-making on personalised treatments leading to improved treatment adherence and risk control. DOTT was found acceptable and usable among stroke survivors and GPs during a series of evaluations.

conclusionsAdopting a user-centred data-driven design approach informed an intervention that is acceptable to users and has the potential to improve patient outcomes. A future feasibility study and subsequent clinical trial will provide evidence of the effectiveness of DOTT in reducing risk of stroke recurrence.

Indexed as

Decision Support TechniquesLearning Health SystemStakeholder ParticipationAgedAged, 80 and overFemaleHumansIntersectoral CollaborationLondonMaleMiddle AgedQualitative ResearchRisk FactorsRisk ManagementSecondary PreventionStrokeDecision Support SystemLearning Health SystemPrimary CareShared Decision MakingStakeholder EngagmentStroke Medicine

Identifiers

PMID31420396
PMCPMC6701575
OpenAlexW2968461535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.